Some nutrition SKUs (product varieties) will likely be affected in the short term, a Reckitt spokesperson said.
According to Reuters, the company could not estimate when the warehouse would be up and running again, but said it was working as quickly as possible with local authorities and regulators to minimise the disruption.
"We are partnering with customers and suppliers on expedited recovery efforts to minimise disruption by leveraging our global supply chain and managing inventory at our other U.S. warehouses," the spokesperson said.
This is not the first time Reckitt has had to rely on its worldwide supply chain in an emergency, which can take time because of the regulatory hurdles the company needs to clear with the U.S. Food & Drug Administration (FDA).
In 2022, during a months-long U.S. shortage of baby formula, Reckitt flew 65 tons of baby formula to Chicago from its plant in Singapore. A few months before, it said it was working with the FDA to increase baby formula supply, including expediting the approval of some products made at a facility in Mexico.
Reckitt said on Wednesday it had comprehensive property damage and business interruption insurance, which it expects will largely offset the impact on earnings.
This marks a third setback for the company this year.
In February, an investigation showed some employees had under-reported liabilities in the Middle East, triggering the biggest one-day drop in Reckitt's shares since December 1999.
A month later, the stock tumbled again after an Illinois jury ordered Reckitt's Mead Johnson unit to pay $60 million to the mother of a premature baby who died of an intestinal disease after allegedly being fed one product made by the company’s Enfamil baby formula brand.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.